In recent research, treatment with osimertinib plus a platinum–pemetrexed chemotherapy combination resulted in statistically ...

Most patients receiving chemotherapy with taxanes or platinum salts develop painful neuropathy in hands and feet, often forcing dose reduction or treatment interruption. • Published in Clinical and ...

Most patients receiving chemotherapy with taxanes or platinum salts develop pain and loss of sensitivity in their hands and feet—a severe side effect that can interfere with proper treatment.

Breast cancer (BRCA) remains the most common malignant cancer in women worldwide. Although a range of treatments exists, ...

Positive opinion based on results of Phase 3 C-POST trial that show Libtayo significantly reduced the risk of disease recurrence or death by 68% compared to placebo (hazard ratio: 0.32; 95% confidence ...

Due to a lack of robust evidence, the benefits and risks of adding chemotherapy directly into the abdominal cavity (intraperitoneal chemotherapy, or IPC) for stomach cancer are unclear.

Proton therapy did not outperform IMRT in quality-of-life outcomes for patients with oropharyngeal cancer. Both treatments achieved similarly strong control and survival, according to new trial ...

Approval based on pivotal Phase 3 C-POST trial showing Libtayo significantly reduced the risk of disease recurrence or death by 68% compared to placebo (hazard ratio: 0.32; 95% confidence interval: 0.

Approval based on pivotal Phase 3 C-POST trial showing Libtayo significantly reduced the risk of disease recurrence or death by 68% compared to ...

REDMOND, Wash. and PRINCETON, N.J., Oct. 17, 2025 /PRNewswire/ -- SystImmune Inc. (SystImmune), a clinical-stage biotechnology company, and Bristol Myers ...